Laboratory Investigation of Drug-Induced Immune Hemolytic Anemia

This version of the course is no longer available.
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Immune Hemolytic Anemias (retired 3/18/2020). Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Immune Hemolytic Anemias (retired 3/18/2020) (online CE course)
Laboratory Investigation of Drug-Induced Immune Hemolytic Anemia

A complete medical history is important when investigating drug-induced immune hemolytic anemia. Patient diagnosis and information about previous transfusions, pregnancies, and medications should be obtained.
  • A DAT should be performed with monospecific reagents.
  • Patient serum should be tested for the presence of alloantibodies by using routine procedures.
  • If no reactivity is observed, the test may be repeated in the presence of the drug.
  • Normal red cells can also be treated and coated with the drug. Negative and positive controls must be tested when using drug-treated red cells. This ensures that any reactivity is interpreted accurately.